Page 7 - South Korean (KOSPI) Pharmaceuticals & Biotech Stocks - Biggest Losers Today

UPDATED Nov 27, 2024

Explore the South Korean (KOSPI) Biggest Losers Today. These Pharmaceuticals & Biotech Stocks have seen the largest drop in Market Cap from the previous trading day.

255 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

A950220

NeoImmuneTech
₩1,270.003.9%-15.9%₩24.2bn/aPS23xn/an/a

A004310

Hyundai Pharmaceutical
₩3,635.001.0%-8.0%₩99.6bn/an/an/a1.0%

A002720

Kukje Pharma
₩5,570.000.9%-0.2%₩112.4bn/aPE27.6xn/a0%

A347740

P&K Skin Research Center
₩2,175.001.9%-12.7%₩61.7bn/aPE11.7xn/a1.4%

A053950

Kyung Nam PharmLtd
₩754.002.2%-50.2%₩57.7bn/aPB0.6xn/an/a

A086820

Bio SolutionLtd
₩17,500.000.9%17.4%₩139.1bn/an/an/an/a

A318160

Cell Bio Human TechLtd
₩3,700.004.2%-3.8%₩31.3bn/aPE36.7xn/an/a

A109820

GeneMatrix
₩2,795.002.4%2.9%₩55.7bn/an/an/an/a

A011040

Kyung Dong Pharmaceutical
₩6,110.000.8%-5.7%₩163.3bn/aPB0.8xn/a6.5%

A446440

Epibiotech
₩12,500.005.0%20.2%₩27.3bn/an/an/an/a

A084990

Helixmith
₩3,045.001.0%-40.8%₩138.8bn/aPS44.2xn/an/a

A388870

Pharos iBio
₩8,630.001.3%-35.9%₩110.1bn/aPB4.9xn/an/a

A086040

Biotoxtech
₩3,270.002.8%-45.0%₩50.6bn/aPS1.4xn/an/a

A002800

Sinsin Pharmaceutical
₩5,500.001.9%-9.8%₩81.9bn/aPE20.9xn/a1.1%

A308080

ViGenCell
₩2,710.003.0%-47.6%₩50.7bn/aPS940.6xn/an/a

A314130

Genome
₩2,930.001.7%-52.6%₩89.2bn/aPS3.8xn/an/a

A348150

KoBioLabs
₩5,880.001.4%-29.2%₩112.4bn/aPS2.2xn/an/a

A347850

D&D Pharmatech
₩39,050.000.4%n/a₩410.1bn/aPS31.1xn/an/a

A261780

CHA Vaccine Research Institute
₩3,700.001.6%-28.0%₩97.3bn/aPS266.8xn/an/a

A086890

ISU Abxis
₩5,010.000.9%-15.9%₩178.3bn/aPS2.9xn/an/a

A007570

Ilyang PharmaceuticalLtd
₩11,310.000.8%-23.6%₩202.1bn/aPB0.9xn/a1.3%

A032300

KOREA PHARMA
₩16,760.000.9%-14.3%₩181.2bn/aPE60.9xn/a0.3%

A063160

CKD Bio
₩22,600.001.3%8.4%₩122.3bn/aPB0.9xn/a0%

A420570

J2KBIO
₩9,830.003.0%n/a₩54.5bn/aPS1.6xS38.3%0%
Page 7 of 11
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.